Jorey Chernett bought $616K of Neuronetics (STIM)
Executed Mar 17, disclosed Mar 18, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Mar 18), the stock returned +16.7% (delay-adjusted); from the execution session (Mar 17), +14.4%. Derived: entry at the session's open, exit at the close 20 sessions later.
Jorey Chernett (10% owner) filed 25 Form 4 reports in the trailing twelve months (25 purchases, 0 sales), most often in AIRS. Across 24 priced purchase filings, the average 21-session return was +13.9% from execution and +12.6% from disclosure (delay-adjusted; derived). The largest single filing was $1.4M of STIM (1,057,400 sh across 2 lots, as filed), executed Mar 18.
Healthcare · Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→100,000 sh × $1.17
Exec May 19
Filed May 20 · 12:39 PM ET STIMPURCHASE Neuronetics, Inc. $636K
475,000 sh × $1.34
Exec May 12
Filed May 13 · 8:31 AM ET STIMPURCHASE Neuronetics, Inc. $309K
200,000 sh across 2 lots
Exec Apr 20
Filed Apr 22 · 9:39 AM ET STIMPURCHASE Neuronetics, Inc. $482K
385,442 sh × $1.25
Exec Mar 30
Filed Mar 30 · 7:41 PM ET STIMPURCHASE Neuronetics, Inc. $675K
500,000 sh × $1.35
Exec Mar 27
Filed Mar 30 · 9:37 AM ET STIMPURCHASE Neuronetics, Inc. $175K
125,000 sh × $1.40
Exec Mar 25
Filed Mar 27 · 9:33 AM ET STIMPURCHASE Neuronetics, Inc. $239K
169,472 sh × $1.41
Exec Mar 20
Filed Mar 23 · 9:34 AM ET STIMPURCHASE Neuronetics, Inc. $1.4M
1,057,400 sh across 2 lots
Exec Mar 18
Filed Mar 20 · 8:51 AM ET